Triparna Ghosh-Choudhury, PhD

Triparna Ghosh-Choudhury, PhD has a diverse work experience spanning across various industries. Currently, they serve as the Director of Strategic Solutions at Jumo Health, where they oversee the development of multicultural resources covering a wide range of health topics. Triparna collaborates with advocacy groups and community organizations globally to ensure the accuracy and accessibility of medical resources.

Prior to their current role, Triparna worked as the Director of Client Engagement at saleSEER, Inc., a data intelligence company specializing in Oncology. Their responsibilities included understanding the medical and commercial objectives of industry clients and applying clinical data solutions across therapeutic areas. Triparna represented ClinicalPath, the largest independent oncology pathways provider in the market.

Triparna also has experience in business development, having worked as a Business Development Consultant at MolecularMatch. In this role, they marketed clinical intelligence solutions to oncologists, pathologists, and labs using liquid biopsies for cancer diagnosis and treatment.

Triparna also has a background in education, having served as a Senior Teaching Assistant for Jack Gill's Life Science Entrepreneurship Course at Rice University. Triparna facilitated classes and organized influential guest speakers to motivate and inspire students.

Earlier in their career, Triparna worked as a Research Associate at UT Southwestern Medical Center at Dallas and as a Student Associate at UTHSCSA.

Overall, Triparna Ghosh-Choudhury, PhD possesses a wealth of experience in strategic solutions, client engagement, business development, education, and research, all within the healthcare and life sciences sectors.

Triparna Ghosh-Choudhury obtained their Bachelor of Science (B.S.) degree in Biology/Biological Sciences, General from St. Mary's University in the years 2005 to 2009. Following their undergraduate studies, they pursued a Doctor of Philosophy (PhD) in Translational Biology and Molecular Medicine at Baylor College of Medicine, completing their doctoral degree between 2010 and 2017.